Takahashi, Makio
Kodama, Sho
Akahane, Maiko
Yamamoto, Shuhei
Yonemoto, Takashi
Seki, Haruhiko
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 15 November 2024
Accepted: 17 January 2025
First Online: 8 February 2025
Change Date: 26 April 2025
Change Type: Update
Change Details: The original online version of this article was revised to correct few errors in article
Change Date: 25 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40122-025-00734-6
Declarations
:
: Makio Takahashi received honoraria and consulting fees from Daiichi Sankyo Co., Ltd. Sho Kodama, Maiko Akahane, and Shuhei Yamamoto are employees of Daiichi Sankyo Co., Ltd. Takashi Yonemoto and Haruhiko Seki are employees of INTAGE Healthcare Inc.
: The study protocol was approved by the Medical Corporation Toukeikai Kitamachi Clinic Ethics Review Board on October 25, 2023; no approval number was issued. All study procedures were conducted in accordance with local and institutional ethical standards, the 1964 Declaration of Helsinki and its later amendments, the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects, the Japanese Act on the Protection of Personal Information, and the revised Personal Information Protection Act. The study was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000052629). All patients provided electronic informed consent to participate in the study; no identifying information is included in the manuscript.